- 1Department of Gynecology, the Fourth Hospital of Hebei Medical University, Hebei, Shijiazhuang, China
- 2Department of Molecular Biology, the Fourth Hospital of Hebei Medical University, Hebei, Shijiazhuang, China
- 3Department of Translation Medicine, Shijiazhuang Ninghong Biotechnology Co., Ltd., Hebei, Shijiazhuang, China
A Corrigendum on
Incorporating genotype information in a precise prediction model for platinum sensitivity in epithelial ovarian cancer
By Du N-Y, Li Y, Zheng H, Liu Y-K, Liu L-S, Xie J and Kang S (2025). Front. Oncol. 14:1461772. doi: 10.3389/fonc.2024.1461772
In the published article, there was an error in the Funding statement. “The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by Hebei Province Medical Science Research Key Project (No. 20230771)”. The correct Funding statement appears below.
“The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by Hebei Province Medical Science Research Key Project (No. 20230771) and the Natural Science Foundation of Hebei Province (No. H2020206535).”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: epithelial ovarian cancer, drug sensitivity, predicting model, single-nucleotide polymorphism, clinical factors
Citation: Du N-Y, Li Y, Zheng H, Liu Y-K, Liu L-S, Xie J and Kang S (2025) Corrigendum: Incorporating genotype information in a precise prediction model for platinum sensitivity in epithelial ovarian cancer. Front. Oncol. 15:1590905. doi: 10.3389/fonc.2025.1590905
Received: 10 March 2025; Accepted: 16 April 2025;
Published: 15 May 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Du, Li, Zheng, Liu, Liu, Xie and Kang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Shan Kang, a2FuZ3NoYW5AaGVibXUuZWR1LmNu